Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Malnutrition 4 Esophageal Neoplasms 3 Head and Neck Neoplasms 2 Weight Loss 1 Stomach Neoplasms 1 Postoperative Complications 1 Pancreatic Neoplasms 1 Nutritional Support 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Muscular Atrophy 1 Lymphoma 1 Hyperphagia 1 Gastrointestinal Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Digestive System Neoplasms 1 Deglutition Disorders 1 Critical Illness 1 Child Nutrition Disorders 1 Cachexia 1

Interventions

Cyclophosphamide 62 Dexamethasone 60 Melphalan 54 Peripheral Blood Stem Cell Transplantation 49 Bortezomib 40 Busulfan 39 fludarabine phosphate 34 Filgrastim 32 Lenalidomide 30 Thalidomide 27 Tacrolimus 25 Antilymphocyte Serum 23 Radiotherapy 22 Mycophenolic Acid 17 Methotrexate 17 Prednisone 15 Etoposide 15 sargramostim 14 Cyclosporine 14 fludarabine 12 Methylprednisolone 11 Granulocyte Colony-Stimulating Factor 11 Calcium Dobesilate 11 Whole-Body Irradiation 10 Doxorubicin 9 Carmustine 9 pomalidomide 8 Vincristine 8 Interferon-alpha 8 Cord Blood Stem Cell Transplantation 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Neoplasms, Plasma Cell × Enteral Nutrition × Clear all

NCT04703985 2023-12-07

GAGNE

University Hospital, Bordeaux

LymphoidPlasma cell

Lymphoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡